featured
Efficacy and Safety of Oral Semaglutide With Flexible Dose Adjustment vs Sitagliptin in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Oral Semaglutide With Flexible Dose Adjustment Versus Sitagliptin in Type 2 Diabetes
Lancet Diabetes Endocrinol 2019 Jun 06;[EPub Ahead of Print], TR Pieber, B Bode, A Mertens, YM Cho, E Christiansen, CL Hertz, SOR Wallenstein, JB BuseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.